Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 5/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | GRN | P28799 | 1/20 | 0.38 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6009834 | 0.84 | TGFBR1 (0.40) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL6009842 | 0.79 | KDM4E (0.40) | MEN1LMNAKMT2AMMEFOLH1 | |
| SCHEMBL6010265 | 0.79 | KDM4E (0.35) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL7362044 | 0.79 | ALDH1A1 (0.51) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL7362042 | 0.79 | ALDH1A1 (0.51) | ALDH1A1MEN1LMNAKMT2AMME | |
| SCHEMBL6009597 | 0.78 | ITGB1 (0.33) | — | |
| SCHEMBL6010454 | 0.77 | FOLH1 (0.46) | FOLH1 | |
| SCHEMBL27259500 | 0.77 | TGFBR1 (0.37) | ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL6010244 | 0.76 | MAPK1 (0.41) | ALDH1A1LMNA | |
| SCHEMBL6010216 | 0.76 | KDM4E (0.37) | MEN1LMNAKMT2AMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105288634-A | Preparation method of glycerin-amino acid deep eutectic solvent | UNIV NANJING AGRICULTURAL | 2016-02-03 | — | — | CN | disclosed |
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | ALDH1A1 819/4885MEN1 2277/4885LMNA 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.